IL17A and neoplasm: To investigate the effect of the inhibition of IL-17A in tumor tissue on systemic and local anti-tumor immunity, we assessed the cytotoxic activity of CD8+ T cells from splenocytes or TILs in the MC38 subcutaneous model.